Lotus Eye Hospital Q4 FY26 results: quarterly loss despite revenue rise
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.8 pts more than Nifty Microcap 250 and 11.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q4 FY26 standalone audited results: revenue from operations rose to Rs 1,360.92 lakh vs Rs 1,151.25 lakh YoY. FY revenue Rs 5,371.41 lakh vs Rs 4,956.25 lakh. Q4 swung to net loss of Rs 31.95 lakh vs profit of Rs 25.23 lakh. FY26 PAT fell to Rs 8.04 lakh (Rs 73.93 lakh). Borrowings of Rs 1,142.97 lakh raised from nil, more than doubling finance costs. Auditor issued unmodified opinion. Internal auditor reappointed for FY27.
Profit fell sharply despite revenue growth; new borrowings raise finance costs and pressure margins